Key Metrics of AstraZeneca
Revenue$26.6B▲ 0.0% YoYFY 2020
Operating income$5.2B▲ 0.0% YoY
Net profit$3.1B▲ 0.0% YoY
Shareholders' equity$15.6B
Market cap$268BAZN · $172.57
Competitors10identified
About AstraZeneca
Part of AstraZeneca.
Sectors
Company details
- Website
- astrazeneca.com
- Founded
- 2026
- Listed
- NYSE: AZN (since 2026)
Operational Areas of AstraZeneca
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameAstraZeneca PLC
TickerAZN
ExchangeNYSE
CountryUnited Kingdom
SEC CIK0000901832
Listed since2026
IndustryBiotechnology: Pharmaceutical Preparations
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttp://www.astrazeneca.com
US market & SEC filings
AZN · NYSE · SEC CIK 0000901832
Last price · 24 Oct 2026
$172.57
+2.45%
Market cap$268B
P/E70.7On FY 2020 diluted EPS
Volume2,773,282
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPOUnited KingdomListed 2026
AZN share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeCambridge Biomedical Campus
GSTIN—
Email—
Websitehttp://www.astrazeneca.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of AstraZeneca
Competitors10identified
Countries2most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Part of BIL Enterprises. | hospitalitybrandbook.com | — | United Kingdom | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
Part of AstraZeneca
AstraZenecaPharmaceuticals & HealthcareAstraZeneca IndiaOther IndustriesASTRAZENECA INDIA PRIVATE LIMITEDPharmaceuticals & HealthcareAstraZeneca KoreaOther Industries
AstraZeneca Pharma Poland Sp. z o.o.Pharmaceuticals & HealthcareCCambridge Antibody TechnologyIT Services & SoftwareBusiness activities and related parties
pharmaceutical industry
Filings
No filings on record yet.